Axonis Therapeutics

Provider of drug discovery services

placeCambridge, Massachusetts, United States calendar_todayFounded 2011 groups14 employees language axonis.us

Social engagement

Social engagement: 5.7K social following, 7 posts in the last 12 months — below the industry typical range.

Investor mix

24 investors on record; lead investors include Alexandria, Cormorant Asset Management, VenBio.

Investor typeCountShare
Venture capital1458%
Accelerator & incubator313%
Other / undisclosed729%

Hiring activity

Hires occasionally

1 role tracked across 1 of the last 12 months

27 Feb 2026 · Senior/Principal Scientist, Medicinal Chemistry · United Kingdom

Based on job postings tracked across public sources.

Recent activity

22 Jun 2026
Event
Success in a Product-First Market: Balancing Lead Asset Focus and Pipeline Potential
25 Mar 2026
Event
MassBio State of Possible Conference
26 Jan 2026
Event
Non-Opioid Pain Therapeutic Summit
Coming soon